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ABSTRACT We report a new mechanism for allelic dominance in regulatory genetic 
interactions that we call binding dominance.  We investigated a biophysical model of gene 
regulation, where the fractional occupancy of a transcription factor (TF) on the cis-regulated 
promoter site it binds to is determined by binding energy (–ΔG) and TF dosage.  Transcription 
and gene expression proceed when the TF is bound to the promoter.  In diploids, individuals 
may be heterozygous at the cis-site, at the TF’s coding region, or at the TF’s own promoter, 
which determines allele-specific dosage.  We find that when the TF’s coding region is 
heterozygous, TF alleles compete for occupancy at the cis sites and the tighter-binding TF is 
dominant in proportion to the difference in binding strength.  When the TF’s own promoter is 
heterozygous, the TF produced at the higher dosage is also dominant.  Cis-site heterozygotes 
have additive expression and therefore codominant phenotypes.  Binding dominance 
propagates to affect the expression of downstream loci and it is sensitive in both magnitude 
and direction to genetic background, but its detectability often attenuates.  While binding 
dominance is inevitable at the molecular level, it is difficult to detect in the phenotype under 
some biophysical conditions, more so when TF dosage is high and allele-specific binding 
affinities are similar. A body of empirical research on the biophysics of TF binding 
demonstrates the plausibility of this mechanism of dominance, but studies of gene expression 
under competitive binding in heterozygotes in a diversity of genetic backgrounds are needed. 
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Introduction 
Mendel (1866) coined the terms dominant and recessive to describe variants that respectively 
appear in 3::1 ratios in first-generation hybrid crosses.  Wright (1934) proposed a plausible 
mechanism, demonstrating theoretically that dominance can arise as a natural consequence of 
functional allelic differences among enzymes that play roles in metabolic pathways.  Alleles 
with reduced function tended to be recessive, and variation in the genetic background could 
modify the degree of dominance.  Kacser and Burns (1981) cast Wright’s mechanism into the 
language of enzyme kinetics and metabolic flux, a mechanism we will call flux dominance, and 
several studies have extended and modified it (e.g., Keightley and Kacser 1987; Keightley 
1996; Bagheri and Wagner 2004).  Since then several other mechanisms have been found to 
produce dominance, including negative regulatory feedback (Omholt et al. 2000), threshold-
based reaction-diffusion systems (Gilchrist and Nijhout 2001), protein-protein interactions 
(Vietia et al. 2013) and epigenetic modifications (Li et al. 2012; Bond and Baulcombe 2014).  In 
general, dominance arises because the relationship between the genotype and the phenotype 
it produces is non-linear (Gilchrist and Nijhout 2001; Vietia et al. 2013). 
Empirical studies have shown that dominance is commonly found in loci involved in gene 
regulation.  In particular, trans-acting alleles (e.g., transcription factors) commonly show 
dominance, whereas the cis-acting sites they regulate only rarely do (Li et al. 2012; Bond and 
Baulcombe 2014; Stupar and Springer 2006; Hughes et al. 2006; Wray 2007).  The mechanism 
is unknown.  We propose that this dominance is an inevitable consequence of differences in 
binding dynamics between trans-acting gene products as they compete for access to the cis 
sites they regulate. The degree of dominance thereby depends on differences in concentration 
and binding affinity of the trans-acting gene products.  Such competitive binding interactions 
are integral to models of multifactorial gene regulation, including nucleosome–transcription-
factor interactions (Tief et al. 2010, 2012), and repressor (Browning and Busby 2004) and 
microRNA function (Thomson and Dinger 2016), but have not been applied to allelic 
interactions.  This form of dominance, which we term binding dominance, propagates through 
regulatory pathways and is modified by polymorphism at other loci in the pathway.  Our 
findings apply to any trans-acting regulatory molecules interacting with cis-acting regulatory 
sites.  Transcription-factor/promoter interactions meet these criteria well and we will develop 
the model using that language.   
Model 
Biophysical models have long been used to study molecular interactions between DNA and 
molecules that bind to it (e.g., Gerland et al. 2002; Tulchinsky et al. 2014; Khatri and Goldstein 
2015).  The central premise of these models is that interactions between regulatory molecules 
and the sites they regulate behave according to the thermodynamic and kinetic principles that 
drive all molecular interactions.  Consistent with empirical data (reviewed in Mueller et al. 
2013), gene expression in these models only ensues while a transcription factor (TF) molecule 
is physically bound to the promoter of the regulated gene.   
In our model, binding is a stochastic process determined by the free energy of association (–
ΔG) between a TF molecule and promoter, which we will call ‘binding energy.’  The fractional 
occupancy θ — the proportion of time a promoter is occupied by a TF molecule, and therefore 
the gene-expression level — depends on –ΔG, and also on dosage NTF, the number of free TF 
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molecules available to bind when the promoter is unoccupied.  We treat NTF and TF 
concentration as synonymous, using the nucleus as unit volume. 
The biophysical model represents interacting TF molecules and the promoter sequence as 
strings of bits of arbitrary length, an approach based in statistical physics and information 
theory (Gerland et al. 2002).  This method of abstraction permits characterization of molecular 
interactions at arbitrary scales, from the state space of electrostatic interaction among atoms to 
amino acid and nucleotide variation, and ultimately, to the genetic basis of variation in those 
molecules.  The binding energy drops in steps of –ΔG1 as m, the proportion of mismatched bits 
over the length of the bitstring, increases (Tief et al. 2010).  The haploid model, a parameter-
reduced form of our model in Tulchinsky et al. (2014; see S1 Text), is 
  (1) 
We use the following notational conventions throughout.  Interacting loci are labeled with letters 
A and B, with C included for 3-locus pathways.  Subscripts indicate allelic variants as in Figure 
1a; those before the letter (e.g., 1A, NTF.1A) refer to promoter alleles and those after the letter 
(e.g., A1) indicate gene-product (coding-region) alleles.  Subscripts are dropped for 
homozygotes (e.g., AA; NTF), and both subscripts are used when both sites vary for an allele 
(e.g., 1A1, 2A2, NTF.1A1).  Arrows indicate allele-specific regulatory interactions (e.g., mA1à1B 
represents bitstring mismatches between TF allele A1 and cis-site allele 1B).   
Diploid model 
In diploids, the allelic forms A1 and A2 of the TF molecule (Figure 1a) compete for occupancy at 
both promoter sites 1B and 2B independently (Tulchinsky et al. 2014) and the total number of 
TF molecules is the sum of those from each TF allele copy (NTF = NTF.1A + NTF.2A).  Under TF 
competition, the fractional occupancy of 1A1 on promoter site 1B in the presence of 2A2 is 
  (2a) 
  (2b) 
where m1A1à1B and m2A2à1B are the proportions of mismatches between the bit strings of 1B vs. 
1A1 and 2A2 respectively, and α2A2à1B is the coefficient of competition with 2A2 (Tulchinsky et al. 
2014).  Fractional occupancies of the other three interactions are calculated analogously.  
The final expression level (φ) is the sum of the fractional occupancies of the four TF-promoter 
pairs, scaled to the range [0, 1] such that there is no expression at minimal fractional 
occupancy, 
  (3) 
θ =
NTF
NTF + exp −mΔG1[ ]
θ1A1→1B =
NTF .1A1
NTF .1A1 +α2A2→1B exp −m1A1→1BΔG1[ ]
α2A2→1B =1+NTF .2A2 exp m2A2→1BΔG1[ ]
φ*= 12 θ1A1→1B +θ2A2→1B( )+ θ1A1→2B +θ2A2→2B( )( )
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  (4) 
where φ* is the unscaled expression.  Maximum fractional occupancy θmax = NTF.sat/(1+ NTF.sat) 
occurs when m = 0, and minimum fractional occupancy θmin occurs when m = 1, for all TF-
promoter pairs when both TF variants are at saturating concentration (i.e., NTF.1A + NTF.2A ≥ 
NTF.sat).  As φ* can be below θmin when NTF < NTF.sat, we set the floor at φ = 0.  As a baseline for 
scaling purposes, we use dosages NTF.1A = NTF.2A = NTF.sat /2 as the allele-specific saturating 
concentrations when m = 0 for both alleles. 
Genotype-phenotype (G-P) map 
We treat the phenotype, P, as being proportional to the expression level of the cis-regulated 
locus, such that P = kφ, and without loss of generality, treat that proportionality constant as k = 
1, such that P = φ.   
In the biophysical model, the bit strings are abstract representations of information content that 
can characterize underlying genetic differences in the interacting molecules.  Equations 1 and 4 
therefore characterize the genotype-phenotype (G-P) map, the rules by which the phenotype is 
generated from the underlying genotype, as a function of binding energy and TF concentration.   
Dominance 
Competition between TF alleles for binding to their cis-regulated sites creates conditions for 
allelic dominance (Tulchinsky et al. 2014).  Following Wright (1934), we use d = (P11 – P12)/(P11 
– P22) as the dominance coefficient, where P12 is the heterozygote phenotype and P11 and P22 
are homozygote phenotypes; allele ‘1’ of the respective locus is thereby the reference allele for 
which dominance is assessed.  Allele 1 is codominant when d = ½, completely dominant at d = 
0 and completely recessive at d = 1.   
If fractional occupancy cannot be measured separately for each allele, then d must be 
assessed phenotypically.  Even strong dominance becomes increasingly difficult to detect as 
φ’s for homozygotes and heterozygotes of both alleles approach equality because the three 
genotypes will have very similar phenotypes; the trait will appear to be unaffected by these loci, 
or the degree of dominance will be obscured by sampling and measurement error. Detectability 
(t) is proportional to the absolute difference between the two homozygote phenotypes, such 
that t = κ |P11 – P22| with proportionality function κ.  In a constant genetic background, κ  is 
some increasing function of the accuracy in the measurement of P (or φ) and the sample size 
of the study.  
3-locus pathways:  propagation and genetic background 
In a linear 3-locus pathway (Figure 1b), locus B codes for a second TF that binds to the 
promoter of locus C, such that there are two regulatory steps, AàB and BàC.  The final 
phenotype is the fractional occupancy at locus C (P = φC).  The promoter and product sites of 
locus B together comprise a single allele (in this 3-locus, 2-allele model), and the doubly 
heterozygous B genotype is denoted 1B12B2. Competitive binding of the A alleles onto the two B 
φ =max φ *−θmin
θmax −θmin
,0⎡
⎣
⎢
⎤
⎦
⎥
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alleles proceeds independently, creating two allele-specific fractional occupancy terms, φ1B1 
and φ2B2, based on Equation 2.  Expression of these B alleles yields separate NTF.1B1 and NTF.2B2 
values, which we calculate as NTF.1B1 = φ1B1 NTF.B.sat/2 and NTF.2B2 = φ2B2 NTF.B.sat/2, such that 
maximal expression of the B locus yields NTF.B.sat.   
Methods  
We considered cases where fractional occupancy and therefore gene expression is maximal 
(φ = P = 1) when binding is maximal (m = 0) and TF concentration is saturating, and that φ  = P 
= 0.5 when m = 0.5 at the same NTF.sat.  Analysis of the role of TF concentration requires 
scaling –ΔG1 to NTF.sat in order to meet these constraints. Substituting Equation 2 into Equation 
3 and solving for –ΔG1, we used –ΔG1 = 2 ln[ NTF.sat / (1 + NTF.sat) ].   
We report results from the cases where NTF.sat takes the values 10, 100 and 1000.  To 
graphically illustrate the effects of detectability, we overlay the genotype-dominance maps with 
white opacity masks, grading from opaque at t = 0 through translucency to transparency at t = 
1, where t is the detectability parameter, with the effect of making the underlying genotype-
dominance map increasingly visible as t increases.  As a heuristic, we treat scaling function κ 
as a constant arbitrarily set to 4 with a maximum of t = 1; i.e., dominance is undetectable when 
homozygote phenotypes are equal and always detectable when their difference equals or 
exceeds 1/4.  
In 3-locus pathways, we used Equations 2 and 4, with appropriate subscripts, to calculate φC.  
For simplicity we assume NTF.sat is the same for both regulatory steps, i.e., NTF.A.sat = NTF.B.sat = 
NTF.sat.  All analyses were done using Mathematica (Wolfram Research, 2015).   
 
Results 
We compare three types of polymorphism (Figure 1a).  Polymorphism in the cis-regulated B 
locus is represented as AAà1B2B; that in the TF protein-coding region is A1A2àBB; and 
variation in TF dosage (i.e., allele-specific NTF as determined by upstream expression) is 
1A2AàBB.  In the 3-locus AAàBBàCC pathway, we consider the propagation and detectability 
of dominance at locus A with respect to expression at downstream locus C (φC) and explore 
genetic-background effects when loci B and C are polymorphic or have imperfect binding. 
Genotype-phenotype maps 
The shapes of the G-P maps differ depending on which site is polymorphic.  In the 1A2AàBB 
case (Figure 2a-c) with maximal TF binding (m = 0), φ is low when both alleles are at low 
dosage (NTF), climbing towards high expression as NTF of both alleles rises to saturating 
concentration NTF.sat.  The effect is very sensitive to NTF.sat such that the region of detectably 
lower φ is confined to the very bottom left corner of Figure 2c when NTF.sat is high.  The drop-off 
in φ is proportional to their sum, NTF, therefore perpendicular to the NTF.1A = NTF.2A diagonal. 
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In the A1A2àBB case (2d-f) at NTF.sat, φ depends on competitive binding of the TF variants to 
the cis-sites they regulate (Equations 2 and 4).  φ is high as long as either TF binds tightly 
(mA1àB or mA2àB is low), yielding a characteristic L-shaped ridge on the density plot, indicating 
dominance of the tighter-binding allele.  Increasing NTF.sat (Figure 2e and 2f) broadens and 
flattens the ridge.   
In the AAà1B2B case (Figure 2g-i), the expression of the two B-allele copies is additive 
(Equation 3) and at NTF.sat, peak φ occurs when both alleles perfectly match the TF (mAà1B = 
mAà2B = 0).  Expression falls away on both axes, leaving a characteristic arc on the density plot 
(Figure 2g), curving opposite the direction of the A1A2àBB case.  Increasing NTF.sat produces a 
more plateaued ridge that extends further out along the mAà1B = mAà2B diagonal, visible as a 
more squared-off arc on the density plot (Figure 2h and 2i).  
Dominance in expression level φ  
Dominance at the A locus with respect to φ emerges in when variation occurs in the TF (the 
1A2AàBB and A1A2àBB cases), with different patterns (Figure 3a-f).  However, when variation 
occurs at the cis site (the AAà1B2B case) expression is always codominant (d = 0.5; not 
illustrated) due to the additivity of the products of locus B (Equation 3).   
When TF binding varies (the A1A2àBB case; Figure 3a-c), the TF allele with higher binding 
affinity (lower m) has a competitive advantage and dominant expression.  The isoclines follow 
the diagonal when m is low but flare at higher m such that the competitive binding effect 
becomes much weaker.  In this range the occupancy of each allele is so low that the TF’s 
effectively cease to compete and the phenotype approaches additivity (i.e., diploid φ∗ of 
Equation 3 approaches haploid θ of Equation 1 as m goes to 1).  NTF.sat has a strong effect on 
dominance due to its effect on competition.  When NTF.sat is high (Figure 3c), small changes in 
binding affinity can produce large changes in d, particularly when m < 0.5, whereas much 
larger changes in m are required for the same effect at NTF.sat = 10 (Figure 3a).  Polymorphism 
in the B locus has no effect on the dominance of A1 in the A1A2à1B2B case. 
When TF dosage varies (the 1A2AàBB case; Figure 3d-f), the A allele with higher NTF is 
dominant.  The isoclines spread linearly from the bottom left corner of the density plot, where 
NTF is low for both alleles, continuing into the region beyond the dotted line where total TF 
concentration is saturating (NTF.1A + NTF.2A ≥ NTF.sat).  This dominance pattern is not substantially 
altered by NTF.sat, nor is it by m < 1 provided that the TF coding region and the cis-site are 
homozygous.  These plots are therefore not shown. 
When TF dosage and binding affinity both vary (the 1A12A2àBB case), the two sources of 
dominance interact cooperatively.  Figure 3h shows the effect of allelic variation NTF.1A1 and 
NTF.2A2 under conditions where mA1àB = 0.1, mA2àB = 0.2, and NTF.sat = 100.  For orientation, 
Figure 3h represents the effects of varying dosage NTF for the binding-strength combination 
lying at the position of the circle in Figure 3b; the circles in the centers of Figure 3b and Figure 
3h represent the same conditions.  At this saturating concentration (i.e., NTF.1A1 = NTF.2A2 = 
NTF.sat /2 at both circles), allele 1A1 is dominant with d = 0.291.  Along the x-axis in Figure 3g, 
increasing the dosage of the more tightly binding 1A1 allele above NTF.sat /2 increases its 
dominance, whereas decreasing its concentration pushes d back towards codominance until 
ultimately dominance is reversed and 1A1 becomes recessive.  Along the y-axis, increasing the 
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dosage of the 2A2 allele also counteracts dominance of the 1A1 allele, but the rate of change is 
much slower, and is only able to reverse the direction of dominance if NTF.1A1 and NTF.2A2 start 
well below NTF.sat/2.   
Dominance is more sensitive to binding affinity than to differences in dosage.  Figure 3g 
reflects the same conditions as Figure 3e but with a 5-fold difference in allele-specific dosages, 
NTF.1A1 = NTF.sat/2 and NTF.2A2 = NTF.sat/10. For orientation, the orange crosses in Figures 3e and 
3g share common parameter settings.  Under these maximum-binding conditions, 1A1 is 
dominant with d = 0.17.  In Figure 3g, codominance is restored when binding of 1A1 is reduced 
by ~20%, becoming recessive beyond that.   
Detectability of dominance in the phenotype 
Figure 4a-f shows the dominance maps of Figure 3a-f overlaid by white opacity masks that 
obscure d in proportion to the similarity of the expression levels in homozygotes.  Existing 
dominance due to dosage differences in the 1A2AàBB case is likely to be hard to detect unless 
NTF.sat is low and the dosages differ strongly (Figure 4d), and is likely to be detectable only in 
loss-of-expression alleles when NTF.sat is high (Figure 4e and 4f).  Detectability is higher in the 
A1A2àBB case especially when NTF.sat is low (Figure 4a).  As NTF.sat increases (Figure 4b and 
4c), the region of low detectability of dominance broadens in the high- and low-expression 
regions of the corresponding G-P maps (Figures 2e and 3f).   
3-locus pathways   
Using a three-locus linear pathway (Figure 1b), we assessed the G-P maps and the dominance 
of the dosage (1A) and binding (A1) sites with respect to expression of locus C (φC).  We will call 
this dominance dAC.  We also examined the effects of genetic background by varying binding in 
the BàC step. 
The G-P map of the TF-dosage case (the 1A2AàBBàCC case) with NTF.sat = 10 (Figure 5a) is a 
steeper version of the 1A2AàBB map (Figure 2a), such that φC is nearly maximal unless NTF.A is 
very low for both A alleles.  Higher values of NTF.sat yield such steep G-P maps at low dosage 
that only virtual double-knockout 1A2A genotypes are able to appreciably reduce locus C’s 
expression (not illustrated).  The G-P map for the TF-binding case (the A1A2àBBàCC case; 
Figure 5b shows NTF.sat = 10) takes the same general form as the A1A2àBB map (Figure 3e), 
but has a broad, high-expression plateau such that far greater AàB mismatch is required for 
an equivalent reduction of φC.  At higher NTF.sat (not illustrated), the region of low expression 
becomes increasingly confined to the top right corner such that only very weak AàB binding 
affects φC at maximal BàC binding.  The plateau becomes even broader and the shape 
squares off as it does for the A1A2àBB maps of Figure 3d-f. 
Dominance at the 1A and A1 sites propagates down the pathway to yield dominance with 
respect to φC.  In the A1A2àBBàCC case, the transition of dAC from dominant to recessive lies 
parallel to the mA1àB = mA2àB diagonal when mBàC = 0 (Figures 5c and 6a), and increasing 
NTF.sat steepens the transition (Figures 5d and 6b).  dAC is weaker and more sensitive to binding 
strength when mBàC = 0.5 but is slightly more detectable (Figure 6c and 6d).  dAC drops rapidly 
between 0.5 ≤ mBàC ≤ 1 and becomes very hard to detect, especially when NTF.sat is high (not 
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shown).  Here, without sensitive assays of expression, even unexpressed, completely 
recessive A alleles may go undetected.   
Despite the differences in their G-P maps, dominance in the 1A2AàBBàCC case is almost 
identical to that of the 1A2AàBB case seen in Figure 3d-f.  However, its detectability (Figure 
7a-f) is much weaker (e.g., compare Figure 7a to Figure 4d). It increases slightly when mBàC = 
0.5 (Figure 7c), but drops to become negligible beyond that (not shown).  For higher levels of 
NTF.sat, dominance will only be detectable when one of the A alleles is unexpressed (Figure 7b 
and 7d) unless assays are extremely sensitive.   
Polymorphism in the genetic background can modify dAC, but the magnitude of the effect 
depends on the background type.  The effect is greatest in the 1A2Aà1B2BàCC case, where 
dosage differences in TF locus A coexist with binding-site variation in the cis site of locus B.  
For illustration, we’ve chosen a combination where dosage of the 1A allele is maximal (NTF.1A = 
NTF.sat /2) and that of the 2A allele is low (NTF.2A = NTF.sat/10), at the position of the square in 
Figure 7a, such that dominance is strong and relatively easy to detect.  Figure 6g shows the 
effect of binding variation in the AàB step, due to variation in the B-locus promoter (mAà1B vs. 
mAà2B; the coding region of TF A is monomorphic), at this dosage combination.  As overall 
AàB binding decreases (mAàB increases), dAC increases (and becomes more detectable) until 
ultimately allele 1A’s becomes recessive.  This effect is less pronounced as NTF.sat increases 
(Figure 6h), and also as the dosage differences decrease (not shown).   
Other foreground/background combinations have weaker effects or none at all, and they mostly 
affect detectability.  In Figure 6e and 6f, we show an example for the A1A2àB1B2àCC case, 
where the genetic background consists of a high-functioning B1 allele (mB1àC = 0) and a low-
function B2 allele (mB2àC = 0.9).  Detectability is somewhat higher relative to the A1A2àBBàCC 
cases (Figure 6a and 6b, respectively) but the effect on dAC is negligible.  In the 
1A2AàB1B2àCC case, detectability of dAC is largely determined by the dominant B allele in the 
BàC step, such that the genotype-dominance maps (not shown) are virtually indistinguishable 
from the 1A2AàBBàCC cases of Figure 7a and 7b.  There is no effect on dAC of variation in the 
C-locus promoter (the A1A2àBBà1C2C and 1A2AàBBà1C2C cases; not illustrated), but it 
reduces detectability by reducing φC. 
Discussion 
We find that dominance emerges in regulatory genetic pathways due to competitive molecular 
interactions between transcription-factor variants in heterozygotes as they bind to their shared 
promoters.  Alleles with higher competitive ability are inevitably dominant with respect to their 
contributions to fractional occupancy.  Dominance effects extend to expression of downstream 
loci in multi-step pathways, and polymorphism therein can generate genetic background 
effects.  However, this form of dominance is likely to be phenotypically detectable only when TF 
dosages or binding strengths are in the range where gene expression levels differ measurably 
among genotypes.  We discuss each of these properties and their implications. 
Binding dominance: a new mechanism for dominance 
Competition between transcription factors for binding to the promoter sites they regulate (Eq 
(2)); the A1A2àBB and 1A2AàBB interactions) represents a novel mechanism of dominance at 
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the molecular level.  The strength of the dominance depends on the biophysical properties of 
the interaction between TF molecules and the promoter sites to which they bind.  When TF 
variants differ in their binding affinities (–ΔG), the variant with higher affinity is dominant (Figure 
3a-c).  Dominance of the competing TF variants is also sensitive to TF availability (NTF; Figure 
3d-f).  This is because when NTF is low, fractional occupancy is likewise low and there is little 
competition at the binding site; the allelic effects approach additivity.  Conversely, at high NTF, 
the more abundant TF allele more often occupies the promoter sequence, driving expression.  
In contrast, polymorphism at the downstream cis-regulatory site (AAà1B2B) cannot contribute 
to dominance.  This is because expression of the cis-regulated gene product, or respectively 
the TF variant, proceeds independently for each allele and overall expression is their sum.  In 
the 3-locus pathway, dominance in locus A can propagate down the pathway, such that A 
alleles can show dominance with respect to expression of locus C (φC; Figures 5c, 5d, 6 and 7) 
as well as to locus B (φB).  
Binding dominance differs from the type of dominance that arises in metabolic pathways, which 
we call flux dominance, though the mechanisms of both are rooted in the biophysics of 
molecular interactions.  In enzymes embedded in metabolic pathways, dominant alleles have 
higher rates of catalysis (kcat), thus producing a higher flux from substrate to product, and the 
degree of dominance is proportional to the difference in kcat values (Kacser and Burns 1981; 
Keightley and Kacser 1987; Keightley 1996). Flux dominance is sensitive to substrate 
saturation of the enzyme (Bagheri-Chaichian et al. 2003), analogous to the way NTF.sat affects 
the degree of binding dominance through fractional occupancy.  Flux dominance doesn’t 
explain the effects of mutations at regulatory loci (Keightley 1996) because regulatory genetic 
pathways don’t experience flux.   
Protein-assembly dominance occurs when some subunits of complex proteins are expressed in 
inappropriate concentrations or have defective structures, disrupting the stoichiometry of 
protein assembly (Veitia 2003; Veitia et al. 2013).  These represent downstream effects in the 
binding-dominance model, where subunit concentrations are determined by allele-specific φ1B1 
and φ2B2, the expression levels of the B1 and B2 structural variants.  The phenotype has a non-
linear relationship to gene expression, or in our notation, P = kφ becomes P = k(φ1B1, φ2B2), 
where k is now a function of the expression levels and binding properties of the other subunits 
in the complex. 
Feedback dominance results from cases where a gene product autoregulates its expression. 
Omholt et al. (2000) analyzed feedback dominance using the biophysically relevant Hill (1910) 
equation that permits serially repeated promoter-site sequences; they considered only cases 
that lacked polymorphism in the TF coding region.  Gene products could regulate either their 
own promoters (in our notation, 1A2Aà1A2A) or the promoters of an upstream TF 
(1A2Aà1B2Bà1A2A).  These pathways resemble the 1A2Aà1B2B and 1A2Aà1B2BàCC cases 
for which we find dominance, suggesting that feedback dominance may ultimately prove to be 
a special case of binding dominance.  To our knowledge, the effects of polymorphism in the 
coding regions, thus competitive binding, on feedback dominance remain unexplored. 
Diffusion dominance arises in network-based regulation of ontogenetic diffusion gradients, 
including morphogen concentrations, their diffusion and decay rates, and the threshold 
concentrations necessary to initiate a phenotypic response (Gilchrist and Nijhout 2001).  Allelic 
variation affecting any of these components can show dominance in network output.  While we 
	 11	
have presented our model in the context of TF-promoter interactions, its principles apply 
broadly to interactions between any genetically determined, interacting regulatory molecules.  
Our simple regulatory pathways represent elements in these more complex diffusion-based 
networks, and we expect that dominance due to competitive binding will be inherent in them.   
Detectability and cryptic dominance 
Biophysical conditions that lead to especially high or low fractional occupancies, determining 
respectively the bottom left and top right corners of the G-P maps (Figuress 2, 5a and 5b), can 
mask dominance because the two homozygotes have very similar phenotypes.  This can occur 
when m is similar for both alleles, or when allele-specific dosage NTF is either high enough to 
saturate the binding site, or low enough that the binding site is rarely occupied by either allele.  
Even strong dominance at the level of molecular interactions can remain cryptic (e.g., compare 
Figure 3d-f to Figure 4d-f).  When NTF.sat is high, only completely unexpressed 1A or 2A alleles 
will be detectable as recessive (Figure 4e and 4f) and moderate to strong dominance will likely 
go undetected.  Likewise, when both TF alleles have similar binding affinities or dosages, the 
alleles will be nearly codominant, lying along the region of the diagonals of Figure 3a-f, but all 
individuals will also have nearly identical phenotypes. There, even polymorphism will be difficult 
to detect without genotyping; the degree of dominance may be of little practical importance in 
these cases anyway.  Nevertheless, we predict that cryptic dominance will become apparent in 
assays of allele-specific expression levels (Mueller et al. 2013) in association with dosage and 
binding-strength variation.   
Detectability of dominance in the 3-locus pathway (Figures 6 and 7) is lower than in the 2-locus 
pathway (Figure 4), because detectability is successively attenuated when it passes through 
NTF of downstream loci.  In the 3-locus pathway, the AàB step determines NTF.B.  In general, 
NTF must be low for differences in NTF to affect expression (Figure 3a-c; this is also why low 
detectability is widespread in the 1A2AàBB case of Figure 4d-f).  It takes relatively large 
changes in expression in the AàB step to appreciatively change NTF.B, and therefore to detect 
differences in expression at loci further downstream. 
Effects of genetic background 
Polymorphism in the genetic background can enhance, obscure, or even reverse binding 
dominance.  There are two types of background effects in the 2-locus regulatory interaction and 
several more in the 3-locus pathway.  In the 2-locus pathway, dominance of coding-site (A1, A2) 
alleles at the TF locus is unaffected by polymorphism in the cis-regulated locus (i.e., dA1A2à1B2B 
= dA1A2àBB).  However, when allele-specific TF dosage and binding affinity (NTF and m) are 
permitted to vary in the 1A12A2àBB case, dominance of coding-site TF variants is affected by 
polymorphism in their promoters (Figure 3g) and vice versa (Figure 3h).  For a given TF 
coding-region (A1A2) heterozygote, dominance modification is asymmetrical, being more 
effective when the dosage of the tighter binding A allele (NTF) is varied (Figure 3h).  In contrast, 
for a given dosage (1A2A) heterozygote, changes in binding affinities of either allele have 
effects of similar magnitude (Figure 3g).  
In the 3-locus pathway, detectability of dAC is further modified by binding strength in the BàC 
step, such that it is least attenuated when mBàC = 0.5 (for NTF.sat = 10, compare Figure 6a and 
6c, also Figure 7a and 7c; for NTF.sat = 100, compare Figure 6b and 6d, also Figure 7b and 7d).  
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This is where the G-P map for the B-locus TF coding region is steepest (Figure 2d-f), therefore 
where |φC.11–φC.22| (the denominator of dAC) is greatest.  dAC becomes almost undetectable when 
mBàC is high because G-P maps are nearly flat there (Figure 2d-f), such that the underlying 2-
locus dominance  is nearly undetectable (Figure 4b and 4c).  Polymorphism at the coding site 
of locus B (the A1A2àB1B2àCC and 1A2AàB1B2àCC cases) modifies detectability only 
negligibly (Figures 6g, 6h, 7g and 7h), because expression at the BàC step incorporates 
dominance of the tighter-binding allele.  Modifying of binding strength mBàC by changing the C-
locus promoter has the same effect on dAC as does changing the B-locus coding region, but 
without the effect of dominance in the BBà1C2C case because expression there is additive. 
Flux dominance is similarly sensitive to allelic substitutions that occur up to several steps 
removed along a metabolic pathway (Kacser and Burns 1981; Keightley 1996).  Bagheri-
Chaichian et al. (2003) show that the downstream dominance effects are sensitive to enzyme 
saturation at intermediate steps, much as we see in binding-site saturation in regulatory 
pathways (Figures 6 and 7).  Feedback dominance likewise shows downstream effects 
(Omholt et al. 2000) in pathways with the structure 1A2AàBBà(1A2A & CC), i.e., where the 
product of locus B co-regulates a downstream locus C as well as upstream locus A.  In this 
case, dominance of the A1 allele is detectable in the expression of locus C.  Omholt et al. 
(2000) did not directly assess attenuation of the signal due to saturation at intermediate steps; 
rather, they noticed and excluded it by considering only cases where homozygotes showed 
differences >25%.   
Binding dominance is likely to interact with flux dominance.  When locus B codes for a 
metabolic enzyme, flux dominance of allele B1 can be modified in 1A2AàB1B2 or A1A2àB1B2 
interactions, provided that regulatory changes in B’s expression levels affect enzyme saturation 
in the three B-locus genotypes.  Polymorphism in both the promoter and product site of the B 
locus, i.e., the 1A2Aà1B12B2 and A1A2à1B12B2 cases, should further influence B1’s flux 
dominance by further changing relative allozyme concentrations.  Conversely, we expect 
changes in allozyme concentration or kcat due to variation in 2B or B2 to modify, mask or expose 
binding dominance at 1A or A1 when dA1 is assessed using genotype-specific fluxes in the 
metabolic pathway.   
Beyond the regulatory pathway, transcription factors interact with other molecules in the cell 
that may be influenced by genetic background. These include direct interactions with proteins 
that regulate TF availability, spurious DNA, RNA or protein binding, and indirect effects of 
physiological conditions such as pH (Mueller et al. 2013).  These affect the NTF/NTF.sat ratio but 
have negligible effect on dominance and its detectability:  the isoclines of Figure 3d-f and the 
detectability gradients of Figure 4d-f are linear, therefore constant with respect to this ratio.  
However, dominance may be modified in cases where TF variants differ in their responses to 
the non-specific background or are regulated differently (i.e., A1A2 cases with properties closer 
to the 1A12A2 case).  For analytical convenience in this study, these secondary binding effects 
are subsumed into NTF (see parameter reduction in S1 Text).  The unreduced model of 
Tulchinsky et al. (2014) may be necessary in the design and interpretation of experiments.   
Empirical studies 
Consistent with the competitive binding model, cis-site heterozygotes typically show additive 
expression whereas trans heterozygotes commonly show dominance (Wray 2007; Guo et al. 
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2008; Tirosh et al. 2010; Zhang et al. 2011; Gruber et al. 2012; Meiklejohn et al. 2014), 
although some cis-site polymorphisms show patterns of dominance as well (Guo et al. 2008; 
Lemos et al. 2008).  Our modeling suggests the possibility that unidentified polymorphism in 
regulatory loci upstream may be involved in at least some of these exceptions.  Motifs with 
variable numbers of binding-site repeats in the promoter region could also potentially produce 
binding dominance and even overdominance, as they do in feedback dominance (Omholt et al. 
2000).   
Mueller et al. (2013) review empirical work on the biophysics of fractional occupancy in 
regulatory interactions.  Gene expression is highly correlated with fractional occupancy of TFs 
on their binding sites, as our model assumes.  Site-specific mutagenesis, using a variety of 
techniques for measuring binding affinity at primary vs. secondary (likely to be spurious 
background) binding sites, reveals strong differences in binding affinity among artificial 
promoter-region alleles (1B and 2B alleles, in our notation).  Some of these techniques are 
themselves based on measures of competitive binding among sites.  Gaur et al. (2013) review 
studies demonstrating that TF and promoter-region alleles show significant patterns of allele-
specific gene expression in diverse model organisms.  Nevertheless, to our knowledge, allelic 
variation in TF binding affinity and concentration, in diverse genetic backgrounds, with respect 
to its effects on competitive binding and heterozygote gene expression remain to be studied. 
Concluding remark 
In the discovery and documentation of regulatory architectures that drive gene expression, it 
has been necessary and appropriate to use inbred lines and careful breeding designs in model 
organisms to control for heterozygosity and to homogenize the genetic background.  Outside of 
the laboratory, polymorphism is ubiquitous.  Our understanding of gene regulation must 
account for it as we learn to predict and manipulate gene expression in the face of multilocus 
heterozygosity, and ultimately as we design and implement new regulatory architectures, in 
diverse systems of importance in medical, agricultural and fundamental research.  A 
comprehensive, quantitative, mechanistically robust theory of Mendelian dominance will likely 
be required, and binding dominance is likely to be a significant component of it.   	
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Figure legends 76	
Figure 1  Diploid 2- and 3-locus regulatory pathways with competitive transcription factor (TF) 77	
binding.  (a) 2-locus pathway:  TF locus A codes for the TF protein that regulates the expressed 78	
locus B.  Locus A can vary at its promoter (alleles 1A & 2A), the coding region (alleles A1 & A2) or 79	
both; locus B varies only at the promoter (1B & 2B).  The dosages of each of the TF alleles 80	
(NTF.1A and NTF.2A) are determined by their promoter sequences.  Subscripts are dropped for 81	
homozygotes.  (b) 3-locus model:  As in the 2-locus pathway, except that locus B codes for a 82	
second TF that goes on to regulate expression of locus C. 83	
Figure 2  Genotype-phenotype maps in the 2-locus regulatory pathway with competitive 84	
transcription factor (TF) binding. Genotype-phenotype maps, shown as density plots of 85	
expression (φ), equivalent to phenotype in this model (φ = P). Rows: Three saturating TF 86	
concentrations (NTF.sat) at maximal binding (mA1àB = mA2àB = 0).  (a-c) Effects of allelic variation 87	
in TF dosage, scaled to NTF.sat.  (d-f) Effects of allelic variation in the TF coding region expressed 88	
as mismatch (m) with a homozygous cis-site promoter BB.  (g-i) Effects of allele-specific 89	
variation in the cis-site, holding the homozygous TF.  Isoclines throughout represent intervals of 90	
0.1 and the black isocline represents φ = 0.5. 91	
Figure 3  Genotype-dominance maps, shown as density plots.  Dominance (d) is with respect to 92	
the TF allele; A1 (or 1A) is dominant in the blue region and recessive in the red. (a-c) A1A2àBB 93	
cases: dominance at the TF coding region.  d as a function of the degree of mismatch (m) 94	
between a homozygous cis site and competing TF-coding alleles A1 and A2, for three saturating 95	
TF concentrations (NTF.sat); the tighter-binding allele (low m) is dominant.  The circle in panel 3b 96	
has the same m and NTF values as the circle in panel 3h. (d-f) 1A2AàBB cases: dominance in 97	
TF dosage.  d as a function of expression level of the two TF alleles 1A and 2A, expressed as a 98	
fraction of the saturating TF dosage (NTF.sat).  TF dosage is saturating (NTF.1A + NTF.2A ≥ NTF.sat) 99	
above the dotted diagonal line.  The higher-dosage TF is dominant.  (g, h) 1A12A2àBB cases.  100	
(g) Dominance as a function of the degree of mismatch in the heterozygous genetic background 101	
where TF alleles differ in dosage, for the case where NTF.1A1 = NTF.sat /2 and NTF.2A2 = NTF.sat /10.  102	
The orange crosses in this and panel 3e have the same m and NTF values.  Above the dotted 103	
line at mA2àB = 0.82552, φaa = 0 for the 2A2 homozygote and d = (φAA–φAa)/ φAA, marking an 104	
discontinuity on the map. (h) Effect of allele-specific concentration in TF in a heterozygous 105	
genetic background, where the TF’s coding region is heterozygous (m1A1àB = 0.1, m2A2àB = 0.2, 106	
NTF.sat = 100).  The circle has the same m and NTF values as the circle in panel 3b.  Isoclines 107	
throughout represent intervals of 0.1 and the thicker white isocline denotes d = 0.5. 108	
Figure 4  Detectability of dominance with respect to genotype.  White opacity-gradient masks 109	
overlay the genotype-dominance maps of the corresponding panels of Figure 3a-f, such that the 110	
intensity of underlying color represents the detectability of dominance.  Isoclines throughout 111	
represent intervals of 0.1 and the thicker white isocline denotes d = 0.5. 112	
Figure 5  Downstream effects of dominance in the 3-locus pathway:  dominance of locus A with 113	
respect to expression at locus C. (a,b) Genotype-phenotype maps with NTF.sat = 10. (c,d) 114	
Genotype-dominance maps of A1A2àBBàCC, with mBàC = 0.  (c) The dotted lines mark 115	
discontinuities:  at high mA1àB beyond the blue dotted line, φAA = 0 for the A1A1 homozygote such 116	
that d = φAa/φaa; at high mA2àB above the red dotted line, φaa = 0 for the A2A2 homozygote such 117	
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that d = (φAA–φAa)/φAA; beyond both lines in the top right corner, d is undefined.  Isoclines 118	
throughout represent intervals of 0.1. 119	
Figure 6  Genetic background effects on dominance in the 3-locus pathway.  Pattern and 120	
detectability of d at the coding site of TF locus A in the 3-locus pathway with respect to 121	
expression at downstream locus C (φC), when TF locus B varies in its coding site.  White 122	
opacity-gradient masks overlay the genotype-dominance maps, proportionally obscuring regions 123	
of low detectability.  Notation: mBàC = {x,y} means that mB1àC = x and mB2àC = y; locus B is 124	
homozygous when x=y. (a-f) Effects of varying binding in the BàC interaction by changing the 125	
coding site of the B-locus TF.  The dotted lines mark discontinuities:  at high mA1àB beyond the 126	
blue dotted line, φAA = 0 for the A1A1 homozygote such that d = φAa/φaa; at high mA2àB above the 127	
red dotted line, φaa = 0 for the A2A2 homozygote such that d = (φAA–φAa)/φAA; beyond both lines in 128	
the top right corner, d is undefined.  (g, h) Effects of changing the B-locus promoter region in the 129	
1A2Aà1B2BàCC case, with detectability overlays.  Low binding in the AàB step reverses the 130	
dominance pattern due to dosage differences of the A alleles. (g) mAà1B vs. mAà2B; NTF.sat = 10, 131	
NTF.1A = NTF.sat/2, NTF.2A = NTF.sat/10.  The orange square at the origin represents the same 132	
parameter conditions as the orange square in Figure 7a; i.e., panel 6g represents a projection 133	
from Figure 7a taken at a point where the dosage of the 1A allele is maximal and that of the 2A 134	
allele is very low.  The dotted lines separate regions where the expression levels of either or 135	
both alleles of locus B (φ1B and φ2B) equal 0 in the genotypes 1A2A and 2A2A.  Those 136	
combinations are shown in Figure S1.  (h) Same, but with NTF.sat = 100.  Isoclines throughout 137	
represent intervals of 0.1. 138	
Figure 7  Pattern and detectability of dominance of allele-specific concentration differences of 139	
TF locus A in the 3-locus pathway, in relation to saturating TF concentration and binding 140	
strength in the BàC step.  (a-d) White opacity-gradient masks overlay the genotype-dominance 141	
maps, proportionally obscuring regions of low detectability.   Notation: mBàC = {x,y} means that 142	
mB1àC = x and mB2àC = y; locus B is homozygous when x = y.  (a) The orange square represents 143	
the same parameter conditions as the orange square in Figure 6g, i.e., Figure 6g examines 144	
genetic-background effects on dominance at a point where the 1A allele has maximal dosage 145	
and the dosage of the 2A allele is very low.  Isoclines throughout represent intervals of 0.1.   146	
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Supporting Information 170	
Parameter reduction in the biophysical model 171	
The biophysical model we analyze is a parameter-reduced version of the model in Tulchinsky et 172	
al. (2014), developed from models of transcription-factor (TF) binding in the statistical physics 173	
literature (Gerland et al. 2002).  The haploid version of that model characterizes fractional 174	
occupancy of the TF on the promoter site it regulates as 175	
  176	
where θ is the fractional occupancy, N'TF is the absolute number of TF molecules,–ΔG is the free 177	
energy of association between a TF molecule and promoter site, and Ediff is the difference 178	
between the free energy of association between a TF molecule to its primary binding site and its 179	
local environmental background, which may include the non-specific binding to the genomic 180	
background as well as inhibitors and other molecules in the nuclear matrix (Mueller et al. 2013). 181	
When Ediff < 0, the background is more attractive and fewer TF’s are available for gene 182	
regulation; when Ediff > 0, the target site is more attractive.  Non-specific binding reduces the 183	
number of TF molecules in solution, making fewer available to interact with the specific binding 184	
site.  We combine the Ediff parameter and their N'TF into a single TF-availability term using NTF = 185	
N'TF*exp(–Ediff), where NTF is the number of unencumbered TF molecules available for regulatory 186	
interactions, such that 187	
  188	
Gerland et al. (2002) estimated that Ediff = ~0 or a little less, so in practice NTF = ~N'TF unless 189	
N'TF is very small. 190	
The bioenergetic model represents the interacting TF molecules and promoter sequence as 191	
strings of bits, where binding decreases with m', the number of mismatching bits.  The second 192	
parameter modification we use is define a fractional mismatch parameter m = m'/n, where n is 193	
the bitstring length. Therefore, our –ΔG1 is equivalent to –nΔG1 of Tulchinsky et al. (2014).  For 194	
resolution in our density plots, we treat n as an arbitrarily large, finite integer.  Reducing n would 195	
increase pixilation in those plots by averaging over blocks of area 1/n2, without affecting the 196	
conclusions. 197	
 198	
 199	
θ =
ʹNTF
ʹNTF + exp −ΔG+Ediff⎡⎣ ⎤⎦
θ =
NTF
NTF + exp −ΔG[ ]
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Figure S1  Genetic-background effects on dominance in the 1A2Aà1B2BàCC case:  201	
modification of the dominance of dosage allele 1A due to binding variation in the cis site of TF 202	
locus B.  The top image is the genotype-dominance map shown in Figure 6g under conditions 203	
NTF.sat = 10, NTF.1A = NTF.sat/2 and NTF.2A = NTF.sat/10 (detectability mask omitted), i.e., where the 204	
dosage of the 1A allele is maximal and that of the 2A allele is very low.  Axes in this map are the 205	
binding strengths mAà1B and mA->2B, i.e., binding variation in the AàB step due to variation in the 206	
cis site of TF locus B, and they project to the images below it.  Regions separated by dotted 207	
lines in Figure 6g are here outlined in white.  Projected below this map are the associated 3-208	
locus G-P maps (φC’s) of the 2A2A homozygote and the 1A2A heterozygote with respect to 209	
variation at the cis site of TF locus B.  For those genotypes, the purple lines bound the regions 210	
where φ1B = 0 (i.e., allele 1B is not expressed in the AàB step, thus NTF.1B = 0) and the orange 211	
lines bound the regions where φ2B = 0 (i.e., allele 2B is not expressed in the AàB step, thus 212	
NTF.2B = 0).   213	
 214	
